These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22546123)

  • 41. [Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer].
    Zhu XW; Wu CS; Yuan SC
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):506-9. PubMed ID: 22967468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?
    Gleisner AL; Mogal H; Dodson R; Efron J; Gearhart S; Wick E; Lidor A; Herman JM; Pawlik TM
    J Am Coll Surg; 2013 Dec; 217(6):1090-100. PubMed ID: 24045143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of lymph node status in superficial esophageal carcinoma.
    Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
    Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R
    Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
    Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
    Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.
    Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S
    Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients?
    Sayed SI; Sharma S; Rane P; Vaishampayan S; Talole S; Chaturvedi P; Chaukar D; Deshmukh A; Agarwal JP; D'cruz AK
    J Surg Oncol; 2013 Sep; 108(4):256-63. PubMed ID: 23893514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymph node ratio as an alternative to pN staging in node-positive breast cancer.
    Vinh-Hung V; Verkooijen HM; Fioretta G; Neyroud-Caspar I; Rapiti E; Vlastos G; Deglise C; Usel M; Lutz JM; Bouchardy C
    J Clin Oncol; 2009 Mar; 27(7):1062-8. PubMed ID: 19164210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.
    Rosenberg R; Engel J; Bruns C; Heitland W; Hermes N; Jauch KW; Kopp R; Pütterich E; Ruppert R; Schuster T; Friess H; Hölzel D
    Ann Surg; 2010 Jun; 251(6):1070-8. PubMed ID: 20485149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients.
    Schiffman SC; McMasters KM; Scoggins CR; Martin RC; Chagpar AB
    J Am Coll Surg; 2011 Jul; 213(1):45-52; discussion 52-3. PubMed ID: 21601490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
    Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
    Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multivariate analysis of clinicopathological factors influencing survival following esophagectomy for cancer.
    Mirnezami R; Rohatgi A; Sutcliffe RP; Hamouda A; Chandrakumaran K; Botha A; Mason RC
    Int J Surg; 2010; 8(1):58-63. PubMed ID: 19897061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy.
    Zhang H; Liang H; Gao Y; Shang X; Gong L; Ma Z; Sun K; Tang P; Yu Z
    Sci Rep; 2016 Dec; 6():38804. PubMed ID: 27941828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The lymph node ratio has limited prognostic significance in melanoma.
    Egger ME; Scoggins CR; Martin RC; Stromberg AJ; Quillo AR; McMasters KM; Callender GG
    J Surg Res; 2013 Jan; 179(1):10-7. PubMed ID: 22967706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What factors affect lymph node yield in surgery for rectal cancer?
    Thorn CC; Woodcock NP; Scott N; Verbeke C; Scott SB; Ambrose NS
    Colorectal Dis; 2004 Sep; 6(5):356-61. PubMed ID: 15335370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic variables in thoracic esophageal squamous cell carcinoma.
    Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
    Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.